Awarded
Estradiolvalerat und Dienogest - DAK-G, KKH (ATC-Code: G03FA15)
- Winners
- 1 A Pharma GmbH, Besins Healthcare Germany GmbH, BG Hexal 1 A Pharma GbR (bestehend aus Hexal AG, 1 A Pharma GmbH), Hexal AG
- Contract value
- no value published
- Bids received
- 3
- Published
- 6 Nov 2025
- Awarded
- 6 Oct 2025
- Contract start
- 1 Apr 2026
- Contract end
- 31 Mar 2028stated
- Region
- Hamburg (DE600)
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| MFT Lösung | Techniker Krankenkasse | treeConsult GmbH | — | 5 Aug 2026 |
| DRG Scoring Software | Techniker Krankenkasse | QuantCo Deutschland GmbH | €1 | 5 Aug 2026 |
| CAFM-Tool | Techniker Krankenkasse | HSDGmbH | — | 4 Aug 2026 |
| Drucker & MFG 2026 Verhandlung | Techniker Krankenkasse | RICOH Deutschland GmbH | — | 4 Aug 2026 |
| Tobramycin LOV (WELT) - DAK-G, KKH (ATC-Code: J01GB01) | Techniker Krankenkasse | Aristo Pharma GmbH, Zentiva Pharma GmbH | — | 30 Jul 2026 |
| Tobramycin LOV (EU) - DAK-G, KKH (ATC-Code: J01GB01) | Techniker Krankenkasse | Chiesi GmbH | — | 30 Jul 2026 |